drugset / Trial / NCT01833065
Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation
RandomizedParallel-groupDouble-blindTreatment
Summary
12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients with Chronic Idiopathic Constipation.
Timeline
- Start
- 2013-04
- Primary completion
- 2014-03
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elobixibat | Small molecule | 5 mg | — |
| Subject | Elobixibat | Small molecule | 10 mg | — |